CHRISTINA NGUYEN: Open Payments
NPI 1770691818 · FLOWERY BRANCH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 33 payments from 7 companies in 2025. Trend: 2023 $869 · 2024 $772 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $501 |
| Lilly USA, LLC | 8 | $336 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: ZEPBOUND, Ozempic, Wegovy, Rybelsus, MOUNJARO, AIRSUPRA, Dexcom G6 Transmitter, LEQVIO.
Industry payments across GA — which companies pay providers there.
